{"id":"https://openalex.org/W7223100626","doi":"https://doi.org/10.1016/j.htct.2026.107419","title":"CLASSIFICA\u00c7\u00c3O AUTOMATIZADA DE NEOPLASIAS DE C\u00c9LULAS B MADURAS POR CITOMETRIA DE FLUXO: VALIDA\u00c7\u00c3O EM VIDA REAL DE UMA ABORDAGEM BASEADA NOS DOIS PRIMEIROS TUBOS DO PAINEL EUROFLOW","display_name":"CLASSIFICA\u00c7\u00c3O AUTOMATIZADA DE NEOPLASIAS DE C\u00c9LULAS B MADURAS POR CITOMETRIA DE FLUXO: VALIDA\u00c7\u00c3O EM VIDA REAL DE UMA ABORDAGEM BASEADA NOS DOIS PRIMEIROS TUBOS DO PAINEL EUROFLOW","publication_year":2026,"publication_date":"2026-10-01","ids":{"openalex":"https://openalex.org/W7223100626","doi":"https://doi.org/10.1016/j.htct.2026.107419"},"language":"en","primary_location":{"id":"doi:10.1016/j.htct.2026.107419","doi":"https://doi.org/10.1016/j.htct.2026.107419","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2026.107419","pdf_url":null,"source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.1016/j.htct.2026.107419","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5159192100","display_name":"Daniele Cherelo DANIEL","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148096","display_name":"Fleury S.A. (Brazil)","ror":"https://ror.org/04q9me654","country_code":"BR","type":"company","lineage":["https://openalex.org/I4210148096"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Daniele Cherelo DANIEL","raw_affiliation_strings":["Grupo Fleury, S\u00e3o Paulo, SP, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grupo Fleury, S\u00e3o Paulo, SP, Brasil","institution_ids":["https://openalex.org/I4210148096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068817423","display_name":"Yumi Maekawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148096","display_name":"Fleury S.A. (Brazil)","ror":"https://ror.org/04q9me654","country_code":"BR","type":"company","lineage":["https://openalex.org/I4210148096"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Yumi H MAEKAWA","raw_affiliation_strings":["Grupo Fleury, S\u00e3o Paulo, SP, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grupo Fleury, S\u00e3o Paulo, SP, Brasil","institution_ids":["https://openalex.org/I4210148096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159164864","display_name":"Ana Gabrielly Lira DA SILVA","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148096","display_name":"Fleury S.A. (Brazil)","ror":"https://ror.org/04q9me654","country_code":"BR","type":"company","lineage":["https://openalex.org/I4210148096"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Ana Claudia Teodoro SILVA","raw_affiliation_strings":["Grupo Fleury, S\u00e3o Paulo, SP, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grupo Fleury, S\u00e3o Paulo, SP, Brasil","institution_ids":["https://openalex.org/I4210148096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000030470","display_name":"T\u00e2nia Tieko Takao Catelan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148096","display_name":"Fleury S.A. (Brazil)","ror":"https://ror.org/04q9me654","country_code":"BR","type":"company","lineage":["https://openalex.org/I4210148096"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"T\u00e2nia Tieko Takao CATELAN","raw_affiliation_strings":["Grupo Fleury, S\u00e3o Paulo, SP, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grupo Fleury, S\u00e3o Paulo, SP, Brasil","institution_ids":["https://openalex.org/I4210148096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5159194345","display_name":"Marcal Cavalcante Andrade SILVA","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148096","display_name":"Fleury S.A. (Brazil)","ror":"https://ror.org/04q9me654","country_code":"BR","type":"company","lineage":["https://openalex.org/I4210148096"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Mar\u00e7al Cavalcante Andrade SILVA","raw_affiliation_strings":["Grupo Fleury, S\u00e3o Paulo, SP, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grupo Fleury, S\u00e3o Paulo, SP, Brasil","institution_ids":["https://openalex.org/I4210148096"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106732418","display_name":"Matheus Vescovi Gon\u00e7alves","orcid":"https://orcid.org/0000-0002-8813-2221","observed_orcids":["https://orcid.org/0000-0002-8813-2221"]},"institutions":[{"id":"https://openalex.org/I4210148096","display_name":"Fleury S.A. (Brazil)","ror":"https://ror.org/04q9me654","country_code":"BR","type":"company","lineage":["https://openalex.org/I4210148096"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Matheus Vescovi GON\u00c7ALVES","raw_affiliation_strings":["Grupo Fleury, S\u00e3o Paulo, SP, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grupo Fleury, S\u00e3o Paulo, SP, Brasil","institution_ids":["https://openalex.org/I4210148096"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5082054869","display_name":"Alex Freire Sandes","orcid":"https://orcid.org/0000-0002-2502-4493","observed_orcids":["https://orcid.org/0000-0002-2502-4493"]},"institutions":[{"id":"https://openalex.org/I4210148096","display_name":"Fleury S.A. (Brazil)","ror":"https://ror.org/04q9me654","country_code":"BR","type":"company","lineage":["https://openalex.org/I4210148096"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Alex Freire SANDES","raw_affiliation_strings":["Grupo Fleury, S\u00e3o Paulo, SP, Brasil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Grupo Fleury, S\u00e3o Paulo, SP, Brasil","institution_ids":["https://openalex.org/I4210148096"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210148096"],"apc_list":{"value":0,"currency":"USD","value_usd":0},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.84099343,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"48","issue":null,"first_page":"107419","last_page":"107419"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.5458999872207642,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.5458999872207642,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.18140000104904175,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.04410000145435333,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/b-cell-malignancies","display_name":"B-cell malignancies","score":0.7540000081062317},{"id":"https://openalex.org/keywords/large-b-cell-lymphoma","display_name":"large B-cell lymphoma","score":0.6940000057220459},{"id":"https://openalex.org/keywords/mantle-cell-lymphoma","display_name":"mantle cell lymphoma","score":0.871999979019165},{"id":"https://openalex.org/keywords/cd5","display_name":"CD5","score":0.3319999873638153},{"id":"https://openalex.org/keywords/cd10","display_name":"CD10","score":0.9120000004768372},{"id":"https://openalex.org/keywords/cd25","display_name":"CD25","score":0.9160000085830688},{"id":"https://openalex.org/keywords/atypical-immunophenotype","display_name":"atypical immunophenotype","score":0.746999979019165},{"id":"https://openalex.org/keywords/diagnostic-agreement","display_name":"diagnostic agreement","score":0.6370000243186951},{"id":"https://openalex.org/keywords/sensitivity-and-specificity","display_name":"sensitivity and specificity","score":0.39399999380111694}],"concepts":[{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.44609999656677246},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4228000044822693},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3499999940395355},{"id":"https://openalex.org/C2986587452","wikidata":"https://www.wikidata.org/wiki/Q938438","display_name":"Statistical analysis","level":2,"score":0.22390000522136688},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.2046000063419342},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.16329999268054962},{"id":"https://openalex.org/C2909546088","wikidata":"https://www.wikidata.org/wiki/Q7249605","display_name":"Proliferation Marker","level":3,"score":0.15209999680519104},{"id":"https://openalex.org/C199083928","wikidata":"https://www.wikidata.org/wiki/Q7060602","display_name":"Cistron","level":4,"score":0.1444000005722046},{"id":"https://openalex.org/C3017712846","wikidata":"https://www.wikidata.org/wiki/Q4891747","display_name":"Tumor immunology","level":4,"score":0.1324000060558319},{"id":"https://openalex.org/C2985213535","wikidata":"https://www.wikidata.org/wiki/Q1626599","display_name":"Reference values","level":2,"score":0.13210000097751617}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1016/j.htct.2026.107419","doi":"https://doi.org/10.1016/j.htct.2026.107419","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2026.107419","pdf_url":null,"source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:6c54a30a62554189b6ce3d162640baf1","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/6c54a30a62554189b6ce3d162640baf1","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Hematology, Transfusion and Cell Therapy, Vol 48, Iss , Pp 107419- (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1016/j.htct.2026.107419","doi":"https://doi.org/10.1016/j.htct.2026.107419","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.htct.2026.107419","pdf_url":null,"source":{"id":"https://openalex.org/S2898598332","display_name":"Hematology Transfusion and Cell Therapy","issn_l":"2531-1379","issn":["2531-1379","2531-1387"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","ki-jl-1","poland-20","russia-white-list-3","scielo"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hematology, Transfusion and Cell Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.8999999761581421,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4409869569","https://openalex.org/W4387748488","https://openalex.org/W4387747949","https://openalex.org/W7116922946","https://openalex.org/W7120791414","https://openalex.org/W7202175400","https://openalex.org/W7127193271","https://openalex.org/W4408796622","https://openalex.org/W4403553848","https://openalex.org/W3216280607"],"abstract_inverted_index":{"Introdu\u00e7\u00e3o":[0],"A":[1,231,287,333,401,432],"classifica\u00e7\u00e3o":[2,83,136,326,331,402],"das":[3],"neoplasias":[4,149,157,170,337,354,362],"de":[5,11,16,28,40,42,56,82,162,175,182,221,229,249,290,415,423,435,462],"c\u00e9lulas":[6],"B":[7,97,150,158,171,338,355,363],"maduras":[8],"por":[9,128],"citometria":[10],"fluxo":[12],"requer":[13],"integra\u00e7\u00e3o":[14],"multidimensional":[15],"m\u00faltiplos":[17],"marcadores":[18],"e":[19,48,80,142,169,197,226,233,239,245,253,261,267,273,279,281,299,310,350,360,387,430,446,464,480],"permanece":[20],"dependente":[21],"da":[22,51,466],"experi\u00eancia":[23],"do":[24,72,257,295,410,451],"analista,":[25],"particularmente":[26,441],"diante":[27],"fen\u00f3tipos":[29,478],"at\u00edpicos,":[30],"sobrepostos":[31],"ou":[32,139,164,180],"popula\u00e7\u00f5es":[33],"biclonais.":[34,144],"Ferramentas":[35],"automatizadas":[36],"baseadas":[37],"em":[38,75,223,385,392,477],"bancos":[39],"dados":[41],"refer\u00eancia":[43,222],"podem":[44],"aumentar":[45],"a":[46,49,210,319,439],"objetividade":[47],"padroniza\u00e7\u00e3o":[50,465],"interpreta\u00e7\u00e3o.":[52],"Avaliamos":[53],"o":[54,219,234],"desempenho":[55],"uma":[57],"plataforma":[58,211],"automatizada":[59,403],"incorporada":[60],"ao":[61],"Infinicyt":[62],"3.0,":[63],"utilizando":[64,404],"apenas":[65,405],"os":[66,112,199,206,314,322,369,380,418],"dois":[67,386,406],"primeiros":[68],"dos":[69,407],"cinco":[70,408],"tubos":[71,409],"painel":[73,411],"EuroFlow,":[74],"casos":[76,124,188,208,324,371,377,397,419,470],"com":[77,98,125,135,173,215,218,325,421,453],"diagn\u00f3stico":[78,126,220],"estabelecido":[79],"situa\u00e7\u00f5es":[81],"imunofenot\u00edpica":[84,137],"desafiadora.":[85],"M\u00e9todos":[86],"Foram":[87,121],"analisados":[88,202],"retrospectivamente":[89],"190":[90],"casos.":[91],"O":[92,145,448],"algoritmo":[93],"compara":[94],"cada":[95],"popula\u00e7\u00e3o":[96],"nove":[99,328],"categorias":[100],"diagn\u00f3sticas,":[101],"sendo":[102],"necess\u00e1ria":[103],"concord\u00e2ncia":[104,216,416],"nas":[105],"oito":[106],"compara\u00e7\u00f5es":[107],"pareadas":[108],"(8/8)":[109],"para":[110,241,247,255,263,269,275,283,292,425,442,472],"classifica\u00e7\u00e3o;":[111],"demais":[113,200,315],"resultados":[114,316,476],"s\u00e3o":[115],"reportados":[116],"como":[117,358,366,460],"n\u00e3o":[118,152,160,340],"classific\u00e1veis":[119,153],"(NC).":[120],"inclu\u00eddos":[122],"130":[123,207],"confirmado":[127],"anatomia":[129],"patol\u00f3gica":[130],"e/ou":[131],"estudos":[132],"citogen\u00e9ticos/moleculares,":[133],"48":[134,323],"inconclusiva":[138],"fen\u00f3tipo":[140],"at\u00edpico":[141],"12":[143,376],"segundo":[146],"grupo":[147],"compreendeu":[148],"CD5\u2212/CD10\u2212":[151,372],"(n":[154,166,177,184],"=":[155,167,178,185],"14),":[156],"CD5+":[159,339],"caracter\u00edsticas":[161],"LLC":[163,242],"MCL":[165,342,349],"22)":[168],"vilosas":[172,356,364],"express\u00e3o":[174],"CD10":[176],"6)":[179],"aus\u00eancia":[181],"CD25":[183],"6).":[186],"Nos":[187,375],"confirmados":[189],"foram":[190,201,305,382],"avaliados":[191],"sensibilidade,":[192,440],"especificidade,":[193],"valores":[194],"preditivos,":[195],"cobertura":[196],"concord\u00e2ncia;":[198],"descritivamente.":[203],"Resultados":[204],"Entre":[205,321],"confirmados,":[209],"classificou":[212,335],"67":[213],"(51,5%),":[214],"exata":[217],"64/67":[224],"(95,5%)":[225],"kappa":[227],"multiclasses":[228],"0,421.":[230],"sensibilidade":[232],"VPP":[235,422],"foram,":[236],"respectivamente,":[237],"84,6%":[238],"100%":[240,246,254,262,268,291,424],"(33/39);":[243],"61,5%":[244],"linfoma":[248,256,276,294],"Burkitt":[250],"(8/13);":[251],"46,2%":[252],"manto":[258],"(6/13);":[259],"33,3%":[260],"HCL":[264,359],"(4/12);":[265],"25%":[266],"LPL":[270,298,429,445],"(1/4);":[271],"21,7%":[272],"83,3%":[274],"folicular":[277],"(10/46);":[278],"66,7%":[280,282],"DLBCL":[284,308,344],"CD10+":[285,357],"(2/3).":[286],"especificidade":[288],"foi":[289],"LLC,":[293,426],"manto,":[296],"HCL,":[297,428,444],"Burkitt.":[300],"Apenas":[301],"tr\u00eas":[302,396],"classifica\u00e7\u00f5es":[303,455],"cruzadas":[304],"observadas:":[306],"BL\u2192FL,":[307],"CD10+\u2192FL":[309],"FL\u2192DLBCL":[311],"CD10+;":[312],"todos":[313,368],"discordantes":[317],"corresponderam":[318],"NC.":[320,374,399],"inconclusiva,":[327],"(18,8%)":[329],"receberam":[330],"automatizada.":[332],"ferramenta":[334,461],"7/22":[336],"LLC/n\u00e3o":[341],"(3":[343],"CD10\u2212,":[345],"2":[346],"LPL,":[347],"1":[348,351],"MZL),":[352],"1/6":[353,361],"CD25\u2212":[365],"MZL;":[367],"14":[370],"permaneceram":[373,398],"biclonais,":[378],"ambos":[379],"clones":[381],"corretamente":[383],"reconhecidos":[384],"pelo":[388],"menos":[389],"um":[390],"clone":[391],"sete,":[393],"predominantemente":[394],"LLC;":[395],"Conclus\u00e3o":[400],"EuroFlow":[412],"apresentou":[413],"95,5%":[414],"entre":[417],"classificados,":[420],"MCL,":[427],"BL.":[431],"elevada":[433],"frequ\u00eancia":[434],"NC,":[436],"entretanto,":[437],"limitou":[438],"FL,":[443],"MCL.":[447],"comportamento":[449],"conservador":[450],"algoritmo,":[452],"poucas":[454],"cruzadas,":[456],"favorece":[457],"sua":[458],"aplica\u00e7\u00e3o":[459],"suporte":[463],"interpreta\u00e7\u00e3o,":[467],"permitindo":[468],"direcionar":[469],"NC":[471],"investiga\u00e7\u00e3o":[473],"complementar.":[474],"Os":[475],"inconclusivos/at\u00edpicos":[479],"amostras":[481],"biclonais":[482],"sugerem":[483],"aplica\u00e7\u00f5es":[484],"adicionais":[485],"que":[486],"requerem":[487],"valida\u00e7\u00e3o":[488],"espec\u00edfica.":[489]},"counts_by_year":[],"updated_date":"2026-11-08T12:12:28.789561","created_date":"2026-10-22T00:00:00"}